Cohort Biomonitoring Study to Evaluate the Biocompatibilty of Resin-based Dental Materials
Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · Aug 17, 2016
Trial Information
Current as of June 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the safety of certain dental materials used for fillings and other restorations in adults. Researchers want to understand how these materials may affect the body, specifically by measuring levels of a chemical called bisphenol A (BPA) in urine and saliva, and by examining changes in DNA. The study will include adults aged 65 to 74, and they will take samples from participants at different times to gather information.
To participate, individuals need to be Caucasian adults without serious health issues, recent oral infections, or conditions that require ongoing medication. Participants can expect to provide urine, saliva, and cheek cell samples, which will be analyzed to assess the impact of the dental materials on their health. It's important to note that those who smoke, drink alcohol, or have had X-rays in the last two months will not be eligible for this study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Caucasian, adults,
- Exclusion Criteria:
- • acute or chronic medical condition, presence of oral inflammatory conditions during the previous 2 weeks, chronic disease requiring intake of drugs, exposure to diagnostic X-rays in the previous 2 months, smoking and consumption of alcohol
About Universitaire Ziekenhuizen Ku Leuven
Universitaire Ziekenhuizen KU Leuven is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. Affiliated with KU Leuven, one of Europe’s premier universities, the institution integrates cutting-edge scientific inquiry with high-quality patient care. It plays a pivotal role in the development and implementation of clinical trials, fostering collaboration between researchers, healthcare professionals, and industry partners to translate scientific discoveries into effective treatments. The hospital's multidisciplinary approach ensures comprehensive patient safety and ethical standards, positioning it as a trusted sponsor in the realm of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leuven, , Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials